Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
29,510,597
-
Share change
-
+2,063,026
-
Total reported value
-
$274,402,530
-
Price per share
-
$9.29
-
Number of holders
-
43
-
Value change
-
+$18,724,219
-
Number of buys
-
17
-
Number of sells
-
36
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q1 2022
As of 31 Mar 2022,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,510,597 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, ARK Investment Management LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, and MORGAN STANLEY.
This page lists
43
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.